文献速递临床试验与 GCP

双示踪剂导航用于腹腔镜根治性胃切除术淋巴结清扫(DANCE试验):一项前瞻性随机临床试验方案

Dual tracer navigation for lymph node dissection in laparoscopic radical gastrectomy (DANCE trial): a protocol for a prospective, randomized clinical trial.
PubMed 文献 · Trials · 2023-10-02

该试验为前瞻性随机对照试验,计划纳入516例受试者,按1:1:1:1随机分为对照组、吲哚菁绿(ICG)组、碳纳米颗粒(CNs)组和双示踪剂组。主要结局为清扫淋巴结数目,次要结局包括阳性率、假阳性率、阴性率、假阴性率、转移淋巴结数目、淋巴结转移与示踪剂染色关系、手术时间、失血量、切口长度、并发症发生率和死亡率、3年无病生存期(DFS)、无进展生存期(PFS)和总生存期(OS)。

要点

  • 双示踪剂(ICG联合CNs)用于腹腔镜胃癌手术淋巴示踪为新方法。
  • 计划随机纳入516例,分对照组、ICG组、CNs组和双示踪剂组。
  • 主要结局为清扫淋巴结数目,次要结局含转移相关指标及3年生存。

核心结论

  • 本研究将探讨双示踪剂用于腹腔镜胃切除术的有效性和安全性。

研究设计与样本

  • 前瞻性随机对照试验,计划纳入516例受试者,按1:1:1:1随机分为对照组、ICG组、CNs组和双示踪剂组。

主要发现

  • 该方案尚未报告试验结果。

关键数值与推荐

  • 主要结局为清扫淋巴结数目。
  • 次要结局包括阳性率、假阳性率、阴性率、假阴性率、转移淋巴结数目、淋巴结转移与示踪剂染色关系、手术时间、失血量、切口长度、并发症发生率和死亡率、3年DFS、PFS和OS。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymph node (LN) metastasis is the most common metastasis route in gastric cancer. Extensive dissection of LNs can significantly improve the prognosis of patients with gastric cancer. Recently, multiple clinical studies have demonstrated that either indocyanine green (ICG) or carbon nanoparticles (CNs) can assist to promote the dissection of LNs during laparoscopic radical gastrectomy. Considering the pros and cons of the two tracers, this study proposed a novel method of dual tracer (ICG combined with CNs) for lymphatic tracing in laparoscopic gastric cancer surgery. METHODS: This trial is a prospective, randomized controlled trial (RCT) with an estimation of 516 participants that randomize into 4 groups (1:1:1:1), namely control group, ICG group, CNs group, and dual tracer group. The primary outcome is the number of dissected LNs. The secondary outcomes include positive rate, false positive rate, negative rate, false negative rate, number of metastatic LNs, relationship between LN metastasis and tracer stained, operation duration, blood loss, incision length, morbidity and mortality rate, 3-year DFS (disease free survival), PFS (progression-free survival), and OS (overall survival). DISCUSSION: This study will investigate the efficacy and safety of a novel strategy using dual tracers for laparoscopic gastrectomy. The protocol has been approved by the Ethics Committee of Nanjing Drum Tower Hospital (2021-361-02). The trial findings will be published in peer-reviewed journals. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2100051309). Registered 18 September 2021, https://www.chictr.org.cn/showproj.html?proj=133764 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lu Y, Ai S, Song P, et al. Dual tracer navigation for lymph node dissection in laparoscopic radical gastrectomy (DANCE trial): a protocol for a prospective, randomized clinical trial. Trials. 2023. PMID: 37784191. doi:10.1186/s13063-023-07676-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。